Research roundup


Debbie Rigby presents the latest research news relevant to pharmacy Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus Previous trial results have suggested that DPP4 inhibitors might increase heart failure (HF) risk in patients with type 2 diabetes mellitus (T2DM). Secondary Analysis of the TECOS randomised controlled

This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacists key in cardiac rehabilitation
Next Forum: What’s the go with the 1 July NDSS changes?